UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Impact of primary care provider density on detection and diagnosis of cutaneous melanoma

PloS one, 2018-07, Vol.13 (7), p.e0200097-e0200097

2018

Volltextzugriff (PDF)

Serum‐based miRNAs in the prediction and detection of recurrence in melanoma patients

Cancer, 2015-01, Vol.121 (1), p.51-59

2015

Volltextzugriff (PDF)

Reexamining the Threshold for Reexcision of Histologically Transected Dysplastic Nevi

JAMA dermatology (Chicago, Ill.), 2016-12, Vol.152 (12), p.1327

2016

Volltextzugriff (PDF)

Outcomes of surgical re-excision versus observation of severely dysplastic nevi: A single-institution, retrospective cohort study

Journal of the American Academy of Dermatology, 2020-01, Vol.82 (1), p.238-240

2020

Volltextzugriff (PDF)

Risk of dementia in older veterans with multiple sclerosis

Multiple sclerosis and related disorders, 2024-02, Vol.82, p.105372-105372, Article 105372

2024

Volltextzugriff (PDF)

Analysis of recurrence patterns in acral versus nonacral melanoma: should histologic subtype influence treatment guidelines?

Journal of the National Comprehensive Cancer Network, 2014-12, Vol.12 (12), p.1706-1712

2014

Volltextzugriff (PDF)

Chapter 9: Sleep Medicine

Neurology, 2023-04, Vol.100 (16_supplement_1)

2023

Volltextzugriff (PDF)

Clinicopathological characteristics at primary melanoma diagnosis as risk factors for brain metastasis

Melanoma research, 2013-12, Vol.23 (6), p.461-467

2013

Volltextzugriff (PDF)

PP6C hotspot mutations in melanoma display sensitivity to Aurora kinase inhibition

Molecular cancer research, 2014-03, Vol.12 (3), p.433-439

2014

Volltextzugriff (PDF)

Impact of Age on the Management of Primary Melanoma Patients

Oncology, 2013-01, Vol.85 (3), p.173-181

2013

Volltextzugriff (PDF)

Expression of miR-16 is not a suitable reference for analysis of serum microRNAs in melanoma patients

Journal of biomedical science and engineering, 2012-11, Vol.5 (11), p.647-651

2012

Volltextzugriff (PDF)

TERT, BRAF, and NRAS Mutational Heterogeneity between Paired Primary and Metastatic Melanoma Tumors

Journal of investigative dermatology, 2020-08, Vol.140 (8), p.1609-1618.e7

2020

Volltextzugriff (PDF)

Abstract 4704: Identification of melanoma mutational tumor heterogeneity using BRAF, NRAS and TERT-promoter mutation-detection assays

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.4704-4704

2019

Volltextzugriff (PDF)

Risk of Subsequent Cutaneous Melanoma in Moderately Dysplastic Nevi Excisionally Biopsied but With Positive Histologic Margins

JAMA dermatology (Chicago, Ill.), 2018-12, Vol.154 (12), p.1401

2018

Volltextzugriff (PDF)

Genetic associations of the interleukin locus at 1q32.1 with clinical outcomes of cutaneous melanoma

Journal of medical genetics, 2015-04, Vol.52 (4), p.231-239

2015

Volltextzugriff (PDF)

Abstract A31: Association between TERT promoter mutations and BRAF/NRAS mutations in patients with primary and metastatic melanoma tumors

Cancer research (Chicago, Ill.), 2015-07, Vol.75 (14_Supplement), p.A31-A31

2015

Volltextzugriff (PDF)

Abstract 2847: Quantitative assessment of circulating BRAF DNA in stage IV melanoma patients undergoing BRAF inhibitor treatment

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.2847-2847

2014

Volltextzugriff (PDF)

Analysis of recurrence patterns in acral versus non-acral melanoma: Should histologic subtype influence treatment guidelines?

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.9052-9052

2014

Volltextzugriff (PDF)

The genetic variants in interleukin locus at 1q32.1 as markers of melanoma survival

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.9094-9094

2014

Volltextzugriff (PDF)

Droplet digital PCR monitoring of BRAF and NRAS plasma DNA as biomarkers of treatment response in stage IV melanoma

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.9019-9019

2014

Volltextzugriff (PDF)

Dissecting the effect of age on immune response in melanoma patients

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.9058-9058

2014

Volltextzugriff (PDF)

Impact of age on treatment of primary melanoma patients

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.9054-9054

2013

Volltextzugriff (PDF)

Genetic variation in immunomodulatory genes as markers of melanoma recurrence-free and overall survival

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.9021-9021

2013

Volltextzugriff (PDF)

The clinical and biologic impact of PPP6C mutations in melanoma

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.9067-9067

2013

Volltextzugriff (PDF)

Clinical utility of serum miRNAs for the prediction and early detection of recurrence in melanoma patients

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.9046-9046

2014

Volltextzugriff (PDF)

1 – 25 von 75

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(66)

Publikationsform

Sprache

Englisch
(75)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Impact of primary care provider density on detection and diagnosis of cutaneous melanoma

Serum‐based miRNAs in the prediction and detection of recurrence in melanoma patients

Reexamining the Threshold for Reexcision of Histologically Transected Dysplastic Nevi

Outcomes of surgical re-excision versus observation of severely dysplastic nevi: A single-institution, retrospective cohort study

Risk of dementia in older veterans with multiple sclerosis

Analysis of recurrence patterns in acral versus nonacral melanoma: should histologic subtype influence treatment guidelines?

Chapter 9: Sleep Medicine

Clinicopathological characteristics at primary melanoma diagnosis as risk factors for brain metastasis

PP6C hotspot mutations in melanoma display sensitivity to Aurora kinase inhibition

Impact of Age on the Management of Primary Melanoma Patients

Expression of miR-16 is not a suitable reference for analysis of serum microRNAs in melanoma patients

TERT, BRAF, and NRAS Mutational Heterogeneity between Paired Primary and Metastatic Melanoma Tumors

Abstract 4704: Identification of melanoma mutational tumor heterogeneity using BRAF, NRAS and TERT-promoter mutation-detection assays

Risk of Subsequent Cutaneous Melanoma in Moderately Dysplastic Nevi Excisionally Biopsied but With Positive Histologic Margins

Genetic associations of the interleukin locus at 1q32.1 with clinical outcomes of cutaneous melanoma

Abstract A31: Association between TERT promoter mutations and BRAF/NRAS mutations in patients with primary and metastatic melanoma tumors

Abstract 2847: Quantitative assessment of circulating BRAF DNA in stage IV melanoma patients undergoing BRAF inhibitor treatment

Analysis of recurrence patterns in acral versus non-acral melanoma: Should histologic subtype influence treatment guidelines?

The genetic variants in interleukin locus at 1q32.1 as markers of melanoma survival

Droplet digital PCR monitoring of BRAF and NRAS plasma DNA as biomarkers of treatment response in stage IV melanoma

Dissecting the effect of age on immune response in melanoma patients

Impact of age on treatment of primary melanoma patients

Genetic variation in immunomodulatory genes as markers of melanoma recurrence-free and overall survival

The clinical and biologic impact of PPP6C mutations in melanoma

Clinical utility of serum miRNAs for the prediction and early detection of recurrence in melanoma patients

Suchergebnisse filtern